Kwiatkowska D, Reich A. The significance of autoantibodies in juvenile dermatomyositis. Biomed Res Int. 2021;2021:5513544. DOI: https://doi.org/10.1155/2021/5513544

Swafford C, Roach ES. Juvenile Dermatomyositis and the Inflammatory Myopathies. Semin Neurol. 2020;40:342–48. DOI: https://doi.org/10.1055/s-0040-1705120

Hoeltzel MF, Oberle EJ, Robinson AB, Agarwal A, Rider LG. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis. Curr Rheumatol Rep. 2014;16:467. DOI: https://doi.org/10.1007/s11926-014-0467-y

Chaudhary H, Loganathan SK, Singh S. Juvenile Dermatomyositis: Controversies and Recent Developments in Management. Indian J Rheumatol. 2020;15:S112–22. DOI: https://doi.org/10.4103/injr.injr_107_20

James T, Cassidy RM, Laxer RE, Carol B. Textbook of Pediatric Rheumatology. Philadelphia: Elsevier; 2011. p. 385-412.

Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403-7. DOI: https://doi.org/10.1056/NEJM197502202920807

Bottai M, Tjärnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, et al. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017;3:e000507. DOI: https://doi.org/10.1136/rmdopen-2017-000507

Gupta P, Shruti S, Chaudhary V, Khullar G, Siraj F. Juvenile Dermatomyositis?: a Case Report and Review of Literature. Cureus. 2019;11:e3935. DOI: https://doi.org/10.7759/cureus.3935

Kim S, Kahn P, Robinson AB, Lang B, Shulman A, Oberle EJ, et al. Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease. Pediatr Rheumatol Online J. 2017;15:1–8. DOI: https://doi.org/10.1186/s12969-016-0134-0

Wu JQ, Lu MP, Reed AM. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. World J Pediatr. 2020;16:31–43. DOI: https://doi.org/10.1007/s12519-019-00313-8

Sulaiman W, Subramaniam R, Sarkan MM, Samhari AA. Overlap syndrome?: dermatomyositis and systemic lupus erythematosus with cerebral lupus and autoimmune hepatitis: a case report. Ann Arthritis Clin Rheumatol. 2021;4:1023. DOI: https://doi.org/10.25259/CSDM_112_2024

Twilt M, Feldman BM. An update on the diagnosis and management of juvenile dermatomyositis. Int J Clin Rheumatol. 2012;7:1-9. DOI: https://doi.org/10.2217/IJR.12.23

Schneider M, Murphy K. Juvenile dermatomyositis: a case study. J Pediatr Health Care. 2011;25:38–43. DOI: https://doi.org/10.1016/j.pedhc.2010.06.017

Papadopoulou C, McCann LJ. The vasculopathy of juvenile dermatomyositis. Front Pediatr. 2018;6:284. DOI: https://doi.org/10.3389/fped.2018.00284

Kobayashi I, Akioka S, Kobayashi N, Iwata N, Takezaki S, Nakaseko H, et al. Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update. Mod Rheumatol. 2020;30:411–23. DOI: https://doi.org/10.1080/14397595.2020.1718866

Sawhney S, Aggarwal A. Pediatric rheumatology?: a clinical viewpoint. Singapore: Springer; 2017. p.116-118.

Thyoka M, Adekunle O, Pilkington C, Walters S, Arthurs OJ, Humphries P, et al. Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis. Rheumatology (Oxford). 2018;57:1661–8. DOI: https://doi.org/10.1093/rheumatology/key144

Sanner H, Sjaastad I, Flatø B. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool. Rheumatology (Oxford). 2014;53:1578–85. DOI: https://doi.org/10.1093/rheumatology/keu146

Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. 2017;76:329–40. DOI: https://doi.org/10.1136/annrheumdis-2016-209247

Varnier GC, Pilkington CA, Wedderburn LR. Juvenile dermatomyositis: novel treatment approaches and outcomes. Curr Opin Rheumatol. 2018;30:650–4. DOI: https://doi.org/10.1097/BOR.0000000000000538